Viewing StudyNCT00028483



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00028483
Status: TERMINATED
Last Update Posted: 2011-10-24
First Post: 2002-01-04

Brief Title: Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Sponsor: Seagen Inc
Organization: Seagen Inc

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
recurrent breast cancer View
stage IV breast cancer View